Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARACOG: Cognitive Function in Prostate Cancer Treated With Darolutamide or Enzalutamide
NCT04335682Phase 2Completed
- Sponsor
- Alliance Foundation Trials
- Start
- Aug 2021
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of darolutamide, enzalutamide in prostate cancer (PCa), sponsored by Alliance Foundation Trials. Started Aug 2021; status: completed.
02
Drugs
darolutamideenzalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04335682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04335682.